Kyle Mikson CFA

Stock Analyst at Canaccord Genuity

(4.15)
# 1,541
Out of 4,476 analysts
424
Total ratings
42%
Success rate
8.1%
Average return

Stocks Rated by Kyle Mikson CFA

Guardant Health
Jul 2, 2026
Reiterated: Buy
Price Target: $135
Current: $167.98
Upside: -19.63%
Caris Life Sciences
Jul 2, 2026
Reiterated: Hold
Price Target: $22
Current: $18.30
Upside: +20.22%
Natera
Jun 23, 2026
Reiterated: Buy
Price Target: $285
Current: $279.32
Upside: +2.03%
Onterris
Jun 18, 2026
Reiterated: Buy
Price Target: $264
Current: $20.92
Upside: +1,161.83%
Biodesix
Jun 18, 2026
Reiterated: Buy
Price Target: $22$27
Current: $21.99
Upside: +22.78%
Oxford Nanopore Technologies plc
Jun 17, 2026
Maintained: Buy
Price Target: 200p
Current: $120.40
Upside: +66.11%
Twist Bioscience
Jun 15, 2026
Initiated Coverage: Buy
Price Target: $90
Current: $99.24
Upside: -9.31%
10x Genomics
Jun 10, 2026
Reiterated: Buy
Price Target: $32
Current: $39.01
Upside: -17.97%
Veracyte
Jun 2, 2026
Reiterated: Hold
Price Target: $42
Current: $57.08
Upside: -26.42%
Tempus AI
Jun 2, 2026
Reiterated: Buy
Price Target: $80
Current: $60.27
Upside: +32.74%
Reiterated: Buy
Price Target: $80
Current: $69.11
Upside: +15.76%
Maintained: Hold
Price Target: $4
Current: $4.33
Upside: -7.62%
Reiterated: Buy
Price Target: $3
Current: $1.07
Upside: +180.37%
Reiterated: Buy
Price Target: $4
Current: $1.62
Upside: +146.91%
Maintained: Buy
Price Target: $8
Current: $4.57
Upside: +75.25%
Reiterated: Buy
Price Target: $3
Current: $1.68
Upside: +78.57%
Maintained: Hold
Price Target: $1
Current: $0.9304
Upside: +7.48%
Maintained: Hold
Price Target: $145
Current: $142.40
Upside: +1.83%
Maintained: Buy
Price Target: $40
Current: $24.11
Upside: +65.91%
Reiterated: Buy
Price Target: $100$75
Current: $67.51
Upside: +11.09%
Reiterated: Hold
Price Target: $150$140
Current: $188.68
Upside: -25.80%
Maintained: Hold
Price Target: $3$5
Current: $0.002
Upside: n/a
Maintained: Buy
Price Target: $13$15
Current: $15.19
Upside: n/a
Initiated Coverage: Buy
Price Target: $8
Current: $5.71
Upside: n/a
Initiated Coverage: Buy
Price Target: $8
Current: $1.40
Upside: n/a
Initiated Coverage: Buy
Price Target: $10
Current: $0.42
Upside: n/a